Now eye care professionals can take a proactive, preventative approach to the growing global problem of age-related macular degeneration (AMD).

Measuring macular pigment optical density (MPOD) – a significant and modifiable risk factor for AMD – the MPS II provides results at speeds as fast as 90 seconds per eye.

“The MPS II is the quickest, most affordable, and most clinically relevant ophthalmic device in the world. It provides an efficient method for determining macular pigment optical density in everyday optometric and ophthalmological practice. I believe it will revolutionize the practice of eye care.“

Stuart P. Richer, OD, PhD
Director, Ocular Preventive Medicine
Captain James A Lovell Federal Healthcare Facility, Chicago, USA